Cardiology (all articles) | Page 43 of 178 | Links Medicus Content Curation & Alerts in Medicine

In one of the largest studies to date, Curran et al. found that #methamphetamine use is as big a risk for #heart #disease as alcohol and cocaine. @UCSFCardiology @LaraGroom #AHAJournals https://t.co/S82YLoVM7r pic.twitter.com/SkmxF3bG7d

— JAHA (@JAHA_AHA) August 12, 2022

RCT | Sustained-release ivabradine hemisulfate in patients with systolic heart failure.

16 Aug, 2022 | 13:01h | UTC

Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure – Journal of the American College of Cardiology

Guideline for use of GLP-1 receptor agonists and SGLT2 inhibitors for cardiorenal risk reduction in adults.

15 Aug, 2022 | 12:29h | UTC

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults – Canadian Journal of Cardiology

Commentary on Twitter (thread – click for more)

https://mobile.twitter.com/CJCJournals/status/1557751107006472193

AHA Scientific Statement | Effects of objective and perceived social isolation on cardiovascular and brain health.

15 Aug, 2022 | 12:31h | UTC

Effects of Objective and Perceived Social Isolation on Cardiovascular and Brain Health: A Scientific Statement From the American Heart Association – Circulation

News Release: Social isolation and loneliness increase the risk of death from heart attack, stroke – American Heart Association

Commentaries:

Social Isolation, Loneliness and Cardiovascular Health: The Art of Listening! – American Heart Association

Loneliness Can Be a Real Heartbreaker, Cardiac Experts Warn – HealthDay

Perspective | Pragmatism in clinical trials: essential, not optional.

15 Aug, 2022 | 12:15h | UTC

Pragmatism in clinical trials: essential, not optional – European Journal of Cardiology (free for a limited period)

Commentary on Twitter

A call for pragmatism in the design and running of clinical trials:https://t.co/bXQ4Wp0x1i #EHJ @escardio pic.twitter.com/ES1X12zTGv

— EHJ Editor-in-Chief (@ehj_ed) August 11, 2022

Clinical Practice Update | The detection, evaluation, and management of dyslipidemia in children and adolescents.

15 Aug, 2022 | 12:12h | UTC

The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update – Canadian Journal of Cardiology

RCT | Omecamtiv Mecarbil does not improve exercise capacity in chronic heart failure with reduced ejection fraction.

15 Aug, 2022 | 12:07h | UTC

Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Author Interview: Can Omecamtiv Mecarbil Improve Peak Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)? – JAMA

Commentaries:

Omecamtiv Mecarbil Fails to Improve Exercise Capacity in HFrEF – Medscape (free registration required)

Omecamtiv mecarbil not associated with improved exercise capacity compared with placebo in patients with chronic heart failure with reduced ejection fraction – Physician’s Weekly

Commentary on Twitter

#OriginalInvestigation: Multicenter randomized clinical trial found that, in patients with chronic #HFrEF, omecamtiv mecarbil did not significantly improve exercise capacity over 20 weeks compared with placebo. @GLewisCardiol https://t.co/f27Y0oya6S

— JAMA (@JAMA_current) July 20, 2022

Cohort Study | Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation.

15 Aug, 2022 | 11:38h | UTC

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF – openheart

Commentary: ‘Obesity Paradox’ in Atrial Fibrillation Challenged as Mortality Climbs With BMI – Medscape (free registration required)

Commentary from the author on Twitter (thread – click for more)

🚨🚨 Really excited about our new paper out in @Open_HeartBMJ

Using the @GARFIELD_reg of newly diagnosed AF patients (n=40,482), we examine the association between height/BMI and risk of AF outcomes. https://t.co/lMDCzDsfHw @TRI_Thrombosis

— Fielder Camm (@cfcamm) August 8, 2022

Harmonization of American and European hypertension guidelines: comparisons, reflections, and recommendations.

12 Aug, 2022 | 15:19h | UTC

Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations – European Heart Journal (also available at Circulation)

Review | Cardiovascular complications of pregnancy-associated COVID-19 infections.

12 Aug, 2022 | 15:14h | UTC

Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections – Journal of the American College of Cardiology

Commentaries:

Pregnant Women Are at Increased Risk of Severe Illness, Complications From COVID-19 – American College of Cardiology

Cardiovascular Complications of COVID-19 in Pregnancy Reviewed – HealthDay

Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function.

12 Aug, 2022 | 15:11h | UTC

Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function – Journal of the American College of Cardiology

Commentaries:

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution – TCTMD

Interpreting the Clinical Implications of Drug-Target Mendelian Randomization Studies – American College of Cardiology

Temporal changes, patient characteristics, and mortality, according to microbiological cause of infective endocarditis: a nationwide study.

12 Aug, 2022 | 14:38h | UTC

Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study – Journal of the American Heart Association

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.

12 Aug, 2022 | 14:48h | UTC

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society – EP Europace

Podcast | Vitamin and mineral supplementation: a USPSTF update.

12 Aug, 2022 | 14:23h | UTC

#345 Vitamin and Mineral supplementation: A USPSTF Update with Dr. Michael Barry – The Curbsiders

Review | How can assessing hemodynamics help to assess volume status?

11 Aug, 2022 | 12:21h | UTC

How can assessing hemodynamics help to assess volume status? – Intensive Care Medicine (free for a limited period)

Cohort Study | Association of gonadotropin-releasing hormone agonists for prostate cancer with cardiovascular disease risk and hypertension in men with diabetes.

11 Aug, 2022 | 11:54h | UTC

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes – JAMA Network Open

Commentary on Twitter

Study showed men with #T2DM on GnRH for prostate cancer had a 53% higher risk of an increase in CVD risk score than those not on GnRH, suggesting the need to control cardiovascular disease risk factors in men with T2DM receiving GnRH. #OrigInvestigation https://t.co/3cJ10PpQGN

— JAMA Network Open (@JAMANetworkOpen) August 8, 2022

Systematic Review | Replacing salt with low‐sodium salt substitutes for cardiovascular health in adults, children and pregnant women.

10 Aug, 2022 | 15:38h | UTC

Replacing salt with low‐sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women – Cochrane Library

Summary: Does using low-sodium salt substitutes (LSSS) instead of regular salt reduce blood pressure and heart disease risks, and is it safe? – Cochrane Library

Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart

Cluster RCT: A household salt substitution intervention is a cost-effective intervention for preventing stroke and improving quality of life.

#ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

M-A | Effects of salt substitutes on clinical outcomes.

10 Aug, 2022 | 15:40h | UTC

Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart

Commentary: Swapping salt for substitutes reduces risk of stroke and heart conditions – study – The Guardian

Replacing salt with low‐sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women – Cochrane Library

Cluster RCT: A household salt substitution intervention is a cost-effective intervention for preventing stroke and improving quality of life.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

Commentary from the author on Twitter

Our latest meta-analysis shows consistent effects of salt substitutes on BP across diverse geographies and populations. Protective effects on clinical outcomes are likely to be generalizable to countries worldwide. https://t.co/C273yK6Bek

— Xuejun Yin (@XuejunYin) August 10, 2022

M-A | Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery.

10 Aug, 2022 | 15:32h | UTC

Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis – JAMA (free for a limited period)

Editorial: Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery – JAMA (free for a limited period)

Author Interview: Coronary Artery Bypass Surgery in 2022 – JAMA

News Release: Two-medication strategy offers both benefit and risk after coronary artery bypass surgery – Weill Cornell Medicine

Stay Updated in Your Specialty